Lizonasia 600 Tablets

Lizonasia 600 Tablets are formulated with Linezolid 600 mg, an oxazolidinone antibiotic effective against multidrug-resistant gram-positive pathogens. It provides precise targeting of tough infections commonly encountered in hospital and critical care settings.

Lizonasia 600 Tablets are widely prescribed for infections where conventional antibiotics fail, ensuring reliable clinical outcomes.

Key Benefits:
• Effective against MRSA (methicillin-resistant Staphylococcus aureus)
• Active against VRE (vancomycin-resistant Enterococcus)
• Reliable option in resistant infections
• Suitable for hospital and community-acquired infections

Indications:
• Skin and soft tissue infections
• Pneumonia (community-acquired and hospital-acquired)
• Septicemia
• Abscesses
• Osteomyelitis
• Endocarditis

Dosage & Administration:
As directed by the physician.

Storage:
Store below 25°C. Protect from light and moisture. Keep out of reach of children.